INVIVYD, INC. (IVVD) Net Margin
- 2026-06-30: Net Margin -310.77%.
- 2026-03-31: Net Margin -301.22%.
- 2025-12-31: Net Margin -64.33%.
- 2025-09-30: Net Margin -79.75%.
Complete source-backed net margin history.
- Available history
- 2024-06-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -310.77% |
| 2026-03-31 | -301.22% |
| 2025-12-31 | -64.33% |
| 2025-09-30 | -79.75% |
| 2025-06-30 | -124.38% |
| 2025-03-31 | -144.10% |
| 2024-12-31 | -133.45% |
| 2024-09-30 | -653.11% |
| 2024-06-30 | -2086.88% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -98.25% |
| 2024-12-31 | -669.42% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |